Home Technologies Market Opportunity Product Portfolio Clinical Investors acura Contact Us Company Need for Abuse Deterrent Products Platforms Recent Press Releases More >> Company Overview Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse. The Centers for Disease Control and Prevention estimates that one person dies every 19 minutes from prescription drug abuse in the United States. For nearly a decade, Acura has been on the forefront of developing solutions to combat this epidemic, with products utilizing the Company’s proprietary abuse deterrent AVERSION® and IMPEDE® Technologies. The first two commercial products utilizing Acura’s tamper-resistant technologies are AVERSION® oxycodone and NEXAFED®. In addition, Acura has seven other abuse deterrent products in development: Hydrocodone bitartrate/acetaminophen tablets, Oxycodone HCl/acetaminophen tablets, Hydromorphone tablets, Morphine tablets, Oxymorphone tablets, Tramadol tablets and Methadone tablets. Copyright © 1998-2014 Acura Pharmaceuticals. All rights reserved. Terms of Use and Privacy Policy Risk FactorsContact Us